Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 3Completed 2Active not recruiting 1

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Nimorazole × Clear all
NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
640 enrolled
Head & Neck

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown
1,252 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT03981068 2020-09-25

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Danish Head and Neck Cancer Group

Phase NA Unknown
20 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡